Reassessing The Changing Outlook For Design Therapeutics Inc (DSGN)
Currently, there are 56.47M common shares owned by the public and among those 32.05M shares have been available to trade. The company’s stock has a 5-day price change of 19.24% and 48.42% over the past three months. DSGN shares are trading 112.83% year to date (YTD), with the 12-month market performance up to 112.83% higher. […]
These Numbers Could Change Investor Views For Design Therapeutics Inc (NASDAQ: DSGN)
Logos Global Management LP recently announced the acquisition of new stake in Design Therapeutics Inc (NASDAQ:DSGN). The institutional investor has increased its shareholding in the Healthcare company by 79.89% to 5.03 million shares with purchase of 2.23 million shares. This fresh investment now brings its stake to 8.99% valued currently at $13.34 million. In addition, […]
